Insider Selling: Cencora (NYSE:COR) CEO Sells 5,096 Shares of Stock

Cencora, Inc. (NYSE:COR) CEO Robert Mauch sold 5,096 shares of the business’s stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the transaction, the chief executive officer owned 66,726 shares of the company’s stock, valued at $23,669,713.98. This represents a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Cencora Price Performance

NYSE COR traded up $0.55 during trading hours on Thursday, reaching $352.30. The company’s stock had a trading volume of 1,162,553 shares, compared to its average volume of 1,128,780. The firm has a market capitalization of $68.34 billion, a price-to-earnings ratio of 44.31, a P/E/G ratio of 1.67 and a beta of 0.66. The company’s 50-day moving average is $348.92 and its two-hundred day moving average is $321.33. The company has a debt-to-equity ratio of 4.32, a current ratio of 0.90 and a quick ratio of 0.55. Cencora, Inc. has a 1-year low of $237.71 and a 1-year high of $377.54.

Cencora (NYSE:COR) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $3.84 earnings per share for the quarter, beating analysts’ consensus estimates of $3.79 by $0.05. The firm had revenue of $83.73 billion for the quarter, compared to analyst estimates of $83.36 billion. Cencora had a net margin of 0.48% and a return on equity of 227.15%. Cencora’s quarterly revenue was up 5.9% compared to the same quarter last year. During the same period last year, the company posted $3.34 EPS. Cencora has set its FY 2026 guidance at 17.450-17.75 EPS. On average, equities analysts predict that Cencora, Inc. will post 15.37 EPS for the current year.

Cencora Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, December 1st. Investors of record on Friday, November 14th were issued a dividend of $0.60 per share. This is a positive change from Cencora’s previous quarterly dividend of $0.55. The ex-dividend date was Friday, November 14th. This represents a $2.40 dividend on an annualized basis and a yield of 0.7%. Cencora’s dividend payout ratio (DPR) is 30.19%.

Analyst Ratings Changes

Several research firms have issued reports on COR. Wells Fargo & Company upped their price objective on shares of Cencora from $354.00 to $405.00 and gave the company an “overweight” rating in a research note on Tuesday, November 11th. Wall Street Zen lowered shares of Cencora from a “buy” rating to a “hold” rating in a research report on Friday, November 28th. Bank of America reduced their price objective on shares of Cencora from $380.00 to $360.00 and set a “neutral” rating for the company in a research note on Monday, January 5th. JPMorgan Chase & Co. upped their target price on shares of Cencora from $344.00 to $417.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 11th. Finally, TD Cowen lifted their price target on shares of Cencora from $350.00 to $400.00 and gave the company a “buy” rating in a research report on Monday, November 10th. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $393.08.

Institutional Investors Weigh In On Cencora

A number of hedge funds and other institutional investors have recently modified their holdings of COR. Atlantic Edge Private Wealth Management LLC lifted its position in Cencora by 70.0% during the second quarter. Atlantic Edge Private Wealth Management LLC now owns 85 shares of the company’s stock valued at $25,000 after buying an additional 35 shares in the last quarter. IAG Wealth Partners LLC acquired a new position in shares of Cencora during the 3rd quarter valued at $30,000. Vermillion & White Wealth Management Group LLC boosted its position in Cencora by 69.4% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock worth $31,000 after purchasing an additional 43 shares during the period. Cloud Capital Management LLC acquired a new stake in Cencora in the 3rd quarter valued at $31,000. Finally, Caitlin John LLC purchased a new position in Cencora in the third quarter valued at about $31,000. 97.52% of the stock is currently owned by hedge funds and other institutional investors.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.